Guiding ATMPs to patients
Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and efficacious patient solutions.
What ATMPs are patients receiving? What ATMP manufacture facilities do we have? What specialist treatment clinics are there? Find out this and more on our ATMP map!
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
Work with us!
Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.
Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.
Find world class facilities, collaborators and resources to drive your ATMP development in Sweden.
News
New Vinnova Project – ”Advanced therapies for future Healthcare”
2019-03-01
At the end of 2018, Vinnova granted funding to an 8-month planning project “Advanced therapies for future healthcare”.
Read more
Melanoma gone following treatment with TILs and DC vaccination.
2019-03-01
Good news from of one of our CAMP Projects "Expansion of GMP Compliant Tumor Infiltrating Lymphocytes (TILs) in Xuri bioreactor".
Read more
Johan Hyllner Head of Cell and Gene Therapy at AZ.
2019-03-01
We are pleased to hear that Johan Hyllner has been recruited to AstraZeneca as Head of their Cell and Gene Therapy program.
Read moreATMP success stories
Resources
Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.
Use this guide to navigate development of your ATMP to Phase I!
What is the difference between a transplant and a cell based ATMP?
Mikael Wiberg and Anna Sandström discuss the potential and challenges for ATMPs (Swedish)
Events
Find courses, training, conferences and more!
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.
See all ATMP relevant organisations here